Results 211 to 220 of about 554,110 (237)
Some of the next articles are maybe not open access.
Antiphospholipid Antibodies in Children
Seminars in Thrombosis and Hemostasis, 1998Lupus anticoagulant (LA) is made up of heterogeneous IgG and IgM antibodies that prolong clotting times in vitro and is associated with an increased rate of both thrombosis and hemorrhage in vivo, although thrombosis is far more common. Many mechanisms of action have been explored, but none explains the coagulation abnormality of every sample tested ...
openaire +2 more sources
Antiphospholipid antibody and antiphospholipid antibody syndrome.
Current opinion in rheumatology, 1992Over the past year, many reports have been published on a variety of clinical manifestations related to antiphospholipid antibodies. The low prevalence of anticardiolipin antibodies with the rare occurrence of thrombosis and a low rate of fetal loss in studies in Malaysia and China showed a potential role for local factors.
openaire +1 more source
Antiphospholipid Antibody Syndromes
Rheumatic Disease Clinics of North America, 1989There is no doubt that in some individuals the presence of antibodies to negatively charged phospholipids currently measured as the lupus anticoagulant, a biologically false positive VDRL, and anticardiolipin antibodies is associated with certain clinical features, in particular, a predisposition to both arterial and venous thrombosis and, in women, to
openaire +2 more sources
Epidemiology of Antiphospholipid Syndrome in the General Population
Current Rheumatology Reports, 2022Alí Duarte-García
exaly
ANTIPHOSPHOLIPID ANTIBODIES AND THROMBOSIS
The Lancet, 1988R A, Asherson +2 more
openaire +2 more sources